MorphoSys AG
MOR | F
Overview
Corporate Details
- ISIN(s):
- DE000A3H2XW6
- LEI:
- 529900493806K77LRE72
- Country:
- Germany
- Address:
- Semmelweisstr. 7, 82152 Planegg
- Website:
- https://www.morphosys.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. Our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical company, we are driven by the urgency to deliver groundbreaking medicines, aspiring to give more life for people with cancer.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-08-27 16:00 |
Regulatory News Service
Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual G…
|
English | 11.5 KB | |
| 2024-08-05 07:30 |
Delisting Announcement
MorphoSys Completes Voluntary Delisting from the Frankfurt Stock Exchange and N…
|
English | 12.1 KB | |
| 2024-07-19 16:46 |
General Meeting Notice
MorphoSys AG: Korrektur: Bekanntmachung der Einberufung zur Hauptversammlung am…
|
German | 259.7 KB | |
| 2024-07-19 15:07 |
General Meeting Notice
MorphoSys AG: Bekanntmachung der Einberufung zur Hauptversammlung am 27.08.2024…
|
German | 259.7 KB | |
| 2024-07-18 16:00 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 4.6 KB | |
| 2024-07-12 22:02 |
Delisting Announcement
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
|
English | 13.2 KB | |
| 2024-07-12 14:34 |
Major Shareholding Notification
Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00
|
English | 12.6 KB | |
| 2024-07-05 16:00 |
Report Publication Announcement
|
English | 3.9 KB | |
| 2024-07-02 16:00 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 14.6 KB | |
| 2024-06-21 16:00 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 14.3 KB | |
| 2024-06-20 08:25 |
Delisting Announcement
MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merge…
|
English | 21.4 KB | |
| 2024-06-20 08:06 |
Major Shareholding Notification
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of …
|
English | 12.3 KB | |
| 2024-06-10 16:01 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 13.4 KB | |
| 2024-06-10 16:00 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 13.4 KB | |
| 2024-06-06 22:19 |
Board/Management Change
Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of Morp…
|
English | 10.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-20 | Cluzel, Dr. Marc | Supervisory board | Buy | None | 775.25 EUR |
| 2023-06-07 | Cluzel, Dr. Marc | Supervisory board | Buy | None | 52,800.00 EUR |
| 2023-06-06 | Cluzel, Dr. Marc | Supervisory board | Buy | None | 24,280.00 EUR |
| 2022-11-30 | Reissner, Thomas | Supervisory board | Buy | None | 13,800.00 EUR |
| 2022-11-30 | Reissner, Thomas | Supervisory board | Buy | None | 7,479.00 EUR |
| 2022-11-30 | Reissner, Thomas | Supervisory board | Buy | None | 4,186.00 EUR |
| 2022-11-30 | Reissner, Thomas | Supervisory board | Buy | None | 2,698.00 EUR |
| 2022-11-29 | Reissner, Thomas | Supervisory board | Buy | None | 8,100.00 EUR |
| 2022-11-29 | Reissner, Thomas | Supervisory board | Buy | None | 5,000.00 EUR |
| 2022-11-28 | Vermeylen, Krisja | Supervisory board | Buy | None | 14,860.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ObsEva SA | Switzerland | OBSN | |
|
ODI Pharma AB | Sweden | ODI | |
|
OncoZenge AB | Sweden | ONCOZ | |
|
Orexo | Sweden | ORX | |
|
Orion Oyj | Finland | ORNAV | |
|
PAION AG | Germany | PA8 | |
|
PEPTONIC Medical AB | Sweden | PMED | |
|
Pharmanutra | Italy | PHN | |
|
PharmaSGP Holding SE | Germany | PSG | |
|
Pharmena S.A. | Poland | PHR |